Duncan Gallagher, Director at Health Catalyst, Inc. (HCAT), sold 4,500 shares at $6.93 ($31K) on 2024-12-30, disclosed to the SEC on 2025-01-02.
Scheduled sale ($31k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |